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Articles
Use of quantitative molecular diagnostic methods to assess 
the aetiology, burden, and clinical characteristics of diarrhoea 
in children in low-resource settings: a reanalysis of the 
MAL-ED cohort study
James A Platts-Mills*, Jie Liu*, Elizabeth T Rogawski, Furqan Kabir, Paphavee Lertsethtakarn, Mery Siguas, Shaila S Khan, Ira Praharaj, 
Arinao Murei, Rosemary Nshama, Buliga Mujaga, Alexandre Havt, Irene A Maciel, Timothy L McMurry, Darwin J Operario, Mami Taniuchi, 
Jean Gratz, Suzanne E Stroup, James H Roberts, Adil Kalam, Fatima Aziz, Shahida Qureshi, M Ohedul Islam, Pimmada Sakpaisal, Sasikorn Silapong, 
Pablo P Yori, Revathi Rajendiran, Blossom Benny, Monica McGrath, Benjamin J J McCormick, Jessica C Seidman, Dennis Lang, Michael Gottlieb, 
Richard L Guerrant, Aldo A M Lima, Jose Paulo Leite, Amidou Samie, Pascal O Bessong, Nicola Page, Ladaporn Bodhidatta, Carl Mason, 
Sanjaya Shrestha, Ireen Kiwelu, Estomih R Mduma, Najeeha T Iqbal, Zulfiqar A Bhutta, Tahmeed Ahmed, Rashidul Haque, Gagandeep Kang, 
Margaret N Kosek, Eric R Houpt, and The MAL-ED Network Investigators†
Summary
Background Optimum management of childhood diarrhoea in low-resource settings has been hampered by 
insufficient data on aetiology, burden, and associated clinical characteristics. We used quantitative diagnostic methods 
to reassess and refine estimates of diarrhoea aetiology from the Etiology, Risk Factors, and Interactions of Enteric 
Infections and Malnutrition and the Consequences for Child Health and Development (MAL-ED) cohort study.
Methods We re-analysed stool specimens from the multisite MAL-ED cohort study of children aged 0–2 years done at 
eight locations (Dhaka, Bangladesh; Vellore, India; Bhaktapur, Nepal; Naushero Feroze, Pakistan; Venda, South Africa; 
Haydom, Tanzania; Fortaleza, Brazil; and Loreto, Peru), which included active surveillance for diarrhoea and routine 
non-diarrhoeal stool collection. We used quantitative PCR to test for 29 enteropathogens, calculated population-level 
pathogen-specific attributable burdens, derived stringent quantitative cutoffs to identify aetiology for individual 
episodes, and created aetiology prediction scores using clinical characteristics.
Findings We analysed 6625 diarrhoeal and 30 968 non-diarrhoeal surveillance stools from 1715 children. Overall, 
64·9% of diarrhoea episodes (95% CI 62·6–71·2) could be attributed to an aetiology by quantitative PCR compared 
with 32·8% (30·8–38·7) using the original study microbiology. Viral diarrhoea (36·4% of overall incidence, 
95% CI 33·6–39·5) was more common than bacterial (25·0%, 23·4–28·4) and parasitic diarrhoea (3·5%, 3·0–5·2). 
Ten pathogens accounted for 95·7% of attributable diarrhoea: Shigella (26·1 attributable episodes per 100 child-years, 
95% CI 23·8–29·9), sapovirus (22·8, 18·9–27·5), rotavirus (20·7, 18·8–23·0), adenovirus 40/41 (19·0, 16·8–23·0), 
enterotoxigenic Escherichia coli (18·8, 16·5–23·8), norovirus (15·4, 13·5–20·1), astrovirus (15·0, 12·0–19·5), 
Campylobacter jejuni or C coli (12·1, 8·5–17·2), Cryptosporidium (5·8, 4·3–8·3), and typical enteropathogenic E coli 
(5·4, 2·8–9·3). 86·2% of the attributable incidence for Shigella was non-dysenteric. A prediction score for shigellosis 
was more accurate (sensitivity 50·4% [95% CI 46·7–54·1], specificity 84·0% [83·0–84·9]) than current guidelines, 
which recommend treatment only of bloody diarrhoea to cover Shigella (sensitivity 14·5% [95% CI 12·1–17·3], 
specificity 96·5% [96·0–97·0]).
Interpretation Quantitative molecular diagnostics improved estimates of pathogen-specific burdens of childhood 
diarrhoea in the community setting. Viral causes predominated, including a substantial burden of sapovirus; however, 
Shigella had the highest overall burden with a high incidence in the second year of life. These data could improve the 
management of diarrhoea in these low-resource settings.
Funding Bill & Melinda Gates Foundation.
Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.
Introduction
Although diarrhoea mortality has declined substantially 
since 1990, diarrhoeal incidence and morbidity remain 
a substantial problem.1–3 Studies of diarrhoea aetiology 
have focused on children presenting to care, but this only 
represents a minority of diarrhoea episodes.4 Improved 
estimates of the aetiology and burden of diarrhoea at the 
community level could help ameliorate this morbidity 
by informing treatment guidelines and public health 
interventions.
The application of molecular diagnostics for entero- 
pathogens has provided increased sensitivity and, 
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through quantification, resolution to identify causes of 
diarrhoea.5,6 These studies have revealed that some 
pathogens, including Shigella, enterotoxigenic Escherichia 
coli, and adenovirus 40/41 have been underestimated as 
causes of diarrhoea. Outside of cholera-endemic settings, 
WHO guidelines7 recommend antimicrobial therapy only 
for children with bloody diarrhoea as a surrogate for 
shigellosis diagnosis. However, in practice antibiotics are 
used much more broadly,8 and the presence of blood in 
stools is a poor marker of Shigella infection.6,9,10 Moreover, 
shigellosis has been associated with mortality inde pen-
dent of dysentery.10 Although broader antibiotic treatment 
of diarrhoea might thus be beneficial, this benefit must 
be weighed against increasing antibiotic resistance, 
which is a growing concern and might disproportionately 
affect children in these settings.11,12
We have previously reported diarrhoea aetiology 
estimates in the Etiology, Risk Factors, and Interactions of 
Enteric Infections and Malnutrition and the Consequences 
for Child Health and Development (MAL-ED) multisite 
birth cohort study,13 using qualitative diagnostics to assess 
a subset of specimens.14 In this study, we retested stool 
specimens from the MAL-ED study using quantitative 
PCR to refine these aetiology estimates, test for a broader 
range of pathogens, and identify clinical characteristics 
that might help discriminate between different causes, 
guide treatment algorithms, and improve antibiotic use 
for children with diarrhoea in low-resource settings.
Methods
Study design and participants
The MAL-ED study design has been previously described.13 
Between November, 2009, and February 2012, children 
were enrolled from the community within 17 days of 
birth at eight locations: Dhaka, Bangladesh; Vellore, India; 
Bhaktapur, Nepal; Naushero Feroze, Pakistan; Venda, 
South Africa; Haydom, Tanzania; Fortaleza, Brazil; and 
Loreto, Peru. Children were included if their mother was 
aged 16 years or older, their family intended to remain in 
the study area for at least 6 months from enrolment, they 
were from a singleton pregnancy, and they had no other 
siblings enrolled in the study. Children with a birthweight 
or enrolment weight of less than 1500 g and children 
diagnosed with congenital disease or severe neonatal 
disease were excluded. All sites received ethics approval 
from their respective governmental, local institutional, 
and collaborating institutional ethics review boards. 
Written informed consent was obtained from the parent 
or guardian of every child.
Surveillance and sample collection
Fieldworkers visited children twice weekly for surveill ance 
of child illnesses, antibiotic use, and vaccine admini-
stration. Diarrhoea was defined as maternal report of 
three or more loose stools in 24 h, or one stool with visible 
blood. Episodes separated by 48 h without study-defined 
diarrhoea were considered distinct episodes. The duration, 
number of loose stools in 24 h, presence of dehydration, 
fever, and vomiting were also recorded for each episode of 
diarrhoea. Dehydration was defined as irritability that was 
difficult to console, increased thirst, loss of skin turgor, 
sunken eyes, or lethargy.7 Diarrhoea for 7 days or more 
was considered a prolonged episode, and a high frequency 
was defined as more than 6 stools in any 24 h period 
during an episode. A diarrhoea severity score was 
calculated for every episode as previously described.14 
Diarrhoeal and monthly non-diarrhoeal surveillance stool 
specimens were collected. Diarrhoea was considered to be 
treated by antibiotics if antibiotic use was reported on any 
day of the diarrhoea episode, and inappropriate antibiotic 
Research in context
Evidence before this study
We searched PubMed for articles published in any language since 
Jan 1, 1990, using the search terms “(diarrhea OR diarrhoea) AND 
(etiology OR aetiology OR cause*) AND (pediatric OR paediatric 
OR infant* OR children) AND cohort AND (PCR OR molecular)”. 
We identified 370 publications, of which four estimated 
pathogen-specific diarrhoea burdens for more than a single 
pathogen from prospective child cohorts. Of these, two used 
a pan-molecular diagnostic approach: the first study was done 
in the USA and the second was done at a single site and did 
not incorporate pathogen quantity.
Added value of this study
This study provides a comprehensive, multisite assessment of 
the aetiology of childhood diarrhoea of any severity using 
quantitative PCR for a broad range of enteropathogens in the 
context of home-based surveillance. This approach provided a 
complete overview of the aetiology and burden of infectious 
diarrhoea and assessed the value of clinical characteristics to 
better target syndromic treatment of diarrhoea in these 
settings. Our study identified several pathogens, including 
Shigella, sapovirus, and adenovirus 40/41, as major aetiologies 
of childhood diarrhoea that were either missed or the burden 
of which was substantially underestimated by previous 
microbiological approaches. These results suggest that 
incorporation of clinical characteristics other than blood 
(such as child age) into antibiotic treatment guidelines 
might be of value.
Implications of all available evidence
Ten enteropathogens are responsible for most cases of infectious 
diarrhoea in children in low-resource settings, including several 
that were previously underestimated. Because of the high 
burden of Shigella, and because only a minority of shigellosis is 
dysenteric, guidelines for antibiotic treatment of childhood 
diarrhoea that focus on dysentery should be reviewed.
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use was defined post hoc on the basis of a microbiological 
gold standard as either unnecessary treatment (ie, 
for non-Shigella diarrhoea) or inappropriate antibiotic 
selection (ie, use of an antibiotic class other than 
fluoroquinolones or macrolides for Shigella diarrhoea).15–18
Stool testing
All diarrhoeal stools and non-diarrhoeal stools collected 
for surveillance for months 1–12, 15, 18, 21, and 
24 were analysed according to a standardised protocol, as 
previously described.14,19 We used all available diarrhoeal 
and monthly non-diarrhoeal stool specimens from 
children who had complete follow-up to age 24 months. 
We used custom-designed TaqMan Array Cards (Thermo 
Fisher, Carlsbad, CA, USA) that compartmentalised 
probe-based quantitative PCR assays for 29 entero -
pathogens. Assays for Plesiomonas shigelloides were 
included on a subset of cards. All procedures, including 
assay validation, nucleic acid extraction, quantitative 
PCR setup, and quality control have been described 
previously (appendix).20,21 Raw stool aliquots were stored 
at –80°C before extraction. Bacteriophage MS2 was used 
as an external control to monitor efficiency of nucleic 
acid extraction and amplification. We included one 
extraction blank per batch and one no-template amplifi-
cation control per ten cards to exclude laboratory 
contamination. The detection of rotavirus was considered 
false positive if obtained within 28 days of rotavirus 
vaccine administration. Both Shigella and enteroinvasive 
E coli can be detected using the ipaH target; however, on 
the basis of previous findings6,22 and for simplicity, we 
considered the detection of ipaH to be consistent with 
Shigella infection.
Statistical analysis
For all analyses, we used the quantification cycle value as 
an inverse measure of pathogen quantity, whereby 
one quantification cycle unit corresponds to a doubling 
in quantity. A quantification cycle of 35 was considered 
the analytical limit of detection. We estimated pathogen-
specific burdens of diarrhoea by calculating attributable 
fractions, which incorporate both the frequency of 
pathogen detection in diarrhoea and the association 
between pathogen quantity and diarrhoea.23 This allowed 
for differential attribution of aetiology based on the 
amount of pathogen nucleic acid present. To estimate 
this association, a generalised linear mixed-effects model 
(GLMM) was fit for each pathogen, whereby the outcome 
was diarrhoea, and predictors were the quantity of the 
modelled pathogen, the quantity of each other pathogen, 
child sex, test batch, child age in 3 month intervals, an 
interaction between pathogen quantity and child age, a 
random slope for each site, and a random intercept for 
each individual. A quadratic term for the quantity of the 
modelled pathogen was considered if the prevalence in 
diarrhoea at any quantity was at least 5% and included 
if it improved model fit on the basis of the Akaike 
information criterion. Non-diarrhoeal stools were 
required to be collected at least 7 days before and after 
any diarrhoea episode. All pathogens with at least one 
detection at any quantity in diarrhoeal stools and any 
association with diarrhoea in single-pathogen analysis 
(ie, the same model but without adjustment 
for other pathogens) were included in the final analysis. 
Attributable fractions were calculated by summing the 
pathogen attributable fraction for each episode (AFe) 
across each of j episodes with the following equation:
where
and ORe is the pathogen-specific and quantity-specific 
odds ratio from the GLMM for each episode. Attributable 
incidence rates were calculated as the product of the 
number of episodes identified by surveillance and the 
attributable fractions divided by the number of child 
years at risk and expressed as rates per 100 child-
years. 95% CIs were estimated by bootstrapping with 
1000 iterations.
To estimate the association between pathogen-
attributable diarrhoea and clinical characteristics, a 
single GLMM was fit for each characteristic and 
included the AFe for each pathogen, child age, a 
quadratic term for age, and nested random effects for 
site and individual. Coefficients were scaled to the AFe 
range for each pathogen. An AFe for non-infectious 
diarrhoea was defined as one minus the sum of all 
pathogen-specific AFes with a lower bound of zero. To 
assess model-based prediction of pathogen-attributable 
episodes, we first identified aetiologic detections for 
each episode, using a stringent quantitative cutoff 
(AFe ≥0·5; appendix). If more than one aetiology was 
identified, the pathogen with the highest AFe was 
considered the primary aetiology, and all others were 
considered secondary aetiologies. We then derived a 
prediction score from a GLMM, with an outcome of an 
aetiologic episode, and predictors of blood in stool, 
fever, prolonged duration, dehydration, vomiting, high 
stool frequency, and child age in 3 month intervals and 
nested random effects for site and individual. The fixed 
effects coefficients were scaled, rounded, and summed. 
We fit a receiver operating characteristic curve, and the 
lowest score that achieved at least 80% specificity was 
selected as the cutoff. For each prediction score, a 
diarrhoea episode was considered positive if it had a 
score greater than or equal to the cutoff. The Youden 
Index24 was calculated as sensitivity + specificity – 1, and 
95% CIs were calculated using the binomial distribution. 
All analyses were done in R version 3.4.3.
1
jΣ
i = 1
j
× AFei
1
ORei
AFei = 1 –
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Role of the funding source
The funder of the study had no role in study design, data 
collection, data analysis, data interpretation, or writing of 
the report. The corresponding author had full access to 
all the data in the study and had final responsibility for 
the decision to submit for publication.
Results
Of 2145 enrolled children, 1715 had complete follow-up to 
24 months, from whom 44 570 stools were collected. Of 
the 44 570 stools collected, 42 630 (95·6%) had sufficient 
specimen available and 40 406 (90·7%) had valid quanti-
tative PCR results for all pathogens included in the 
aetiology analysis (table 1; appendix). After excluding 
non-diarrhoeal stools collected within 7 days of a 
diarrhoeal episode, and pathogens with no association 
with diarrhoea in univariate analysis, 6625 diarrhoeal 
and 30 968 non-diarrhoeal stools and 27 pathogens 
were examined for aetiology (appendix). The modelled 
associations between pathogen quantity and diarrhoea 
were robust for age and diarrhoea severity (appendix). 
420 children without complete follow-up were excluded 
from quantitative PCR testing; using the original 
microbiological work-up, the prevalence of pathogens in 
diarrhoea was similar between children who were and 
were not included in the quanti tative PCR testing 
(appendix).
In the first year of life, the incidence of diarrhoea 
was 304·9 episodes per 100 child-years, and rotavirus 
(23·9 episodes per 100 child-years, 95% CI 20·7–27·6), 
adenovirus 40/41 (20·9, 17·4–25·8), sapovirus (18·1, 
13·4–23·3), norovirus (16·4, 13·7–22·6) and enter- 
otoxigenic E coli (14·9, 12·0–20·2) had the highest attribu-
table incidences. In the second year of life, diarrhoea 
incidence was 242·7 episodes per 100 child-years, 
and Shigella (41·3, 95% CI 37·8–46·5), sapovirus 
(27·8, 23·4–33·4), enterotoxigenic E coli (22·8, 
19·1–29·3), rotavirus (17·7, 15·5–20·6) and adenovirus 
40/41 (17·2, 14·3–22·2) had the highest attributable 
incidence (figure 1). Across both years, diarrhoea 
incidence was 273·8 episodes per 100 child-years, and 
95·7% of attributable diarrhoea was attributed to ten 
pathogens: Shigella (26·1 attributable episodes per 
100 child-years, 95% CI 23·8–29·9), sapovirus 
(22·8, 18·9–27·5), rota virus (20·7, 18·8–23·0), adenovirus 
40/41 (19·0, 16·8–23·0), enterotoxigenic E coli (18·8, 
16·5–23·8), noro virus (15·4, 13·5–20·1), astrovirus (15·0, 
12·0–19·5), Campylobacter jejuni or C coli (12·1, 8·5–17·2), 
Cryptosporidium (5·8, 4·3–8·3), and typical enter- 
opathogenic E coli (5·4, 2·8–9·3). Although there were 
differences in the pathogen hier archy by site (figure 2 and 
appendix), the top five aetiologies at each site came 
from these ten pathogens with the exception of 
enteroaggregative E coli, which had the third highest 
incidence in Fortaleza, Brazil (4·0 episodes per 
100 child-years, 95% CI 0·2–9·8) and fifth highest in 
Haydom, Tanzania (9·7, 0·7–28·9). A more stringent 
definition of non-diarrhoeal stools which excluded those 
collected within 28 days of diarrhoea increased 
attributable incidence by more than one episode per 
100 child-years for norovirus (2·4 episodes per 
100 child-years), C jejuni or C coli (2·4), sapovirus (2·0), 
Cryptosporidium (1·9), and enterotoxigenic E coli (1·2; 
appendix). At the time of the study, rotavirus vaccine had 
been introduced to the national programmes of Brazil, 
Peru, and South Africa. Rotavirus was responsible for 
8·9% of all attributable incidence among countries in 
which rotavirus vaccine had not been introduced (the 
second highest pathogen-specific burden) and only 
4·2% among countries where rotavirus vaccine had 
been introduced (the eighth highest pathogen-specific 
burden). Shigella had the highest attributable burden of 
moderate-to-severe diarrhoea using the definition created 
for the Global Enteric Multicenter Study,6 whereas 
rotavirus had the highest burden of severe diarrhoea 
using a modified Vesikari score (appendix).14
Children 
enrolled
Children with 
follow-up to 
24 months
Diarrhoea 
episodes 
reported
Diarrhoea stools 
collected from 
unique episodes
Diarrhoea 
stools available 
for testing
Diarrhoea 
stools with 
valid results*
Surveillance 
stools 
collected
Surveillance 
stools available 
for testing
Surveillance 
stools with 
valid results*
Surveillance stools 
included in the 
aetiology analysis†
Dhaka, Bangladesh 265 210 1520 1438 (94·6%) 1392 (96·8%) 1374 (98·7%) 4528 4353 (96·1%) 4267 (98·0%) 3787
Vellore, India 251 227 960 722 (75·2%) 675 (93·5%) 623 (92·3%) 5058 4924 (97·4%) 4689 (95·2%) 2767
Bhaktapur, Nepal 240 227 1060 955 (90·1%) 911 (95·4%) 899 (98·7%) 5160 5065 (98·2%) 5011 (98·9%) 4457
Naushero Feroze, 
Pakistan
277 246 3110 2123 (68·3%) 1871 (88·1%) 1789 (95·6%) 4871 4676 (96·0%) 4499 (96·2%) 4518
Venda, South Africa 314 237 295 179 (60·7%) 147 (82·1%) 113 (76·9%) 5399 5160 (95·6%) 4428 (85·8%) 3458
Haydom, Tanzania 262 209 537 178 (33·1%) 164 (92·1%) 155 (94·5%) 4657 4345 (93·3%) 4033 (92·8%) 3833
Fortaleza, Brazil 233 165 168 117 (69·6%) 100 (85·5%) 88 (88·0%) 3242 2994 (92·4%) 2795 (93·4%) 4291
Loreto, Peru 303 194 1742 1642 (94·3%) 1617 (98·5%) 1584 (98·0%) 4301 4236 (98·5%) 4059 (95·8%) 3857
Total 2145 1715 9392 7354 (78·3%) 6877 (93·5%) 6625 (96·3%) 37 216 35 753 (96·1%) 33 781 (94·5%) 30 968
Data are n or n (%). *Valid results required for all 27 enteropathogens included in the aetiology analysis (Plesiomonas was included on a subset of cards [5015 of 6877 tested diarrhoeal stools and 32 276 of 
35 753 tested surveillance stools]). †For the aetiology analysis, only surveillance stools that were collected at least 7 days both before and after any reported episode of diarrhoea were included.
Table 1: Diarrhoea surveillance, sample collection, and stool testing by quantitative PCR in the MAL-ED cohort
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Figure 1: Attributable 
incidence of 
pathogen-specific diarrhoea 
at ages 0–11 months (A) and 
12–24 months (B) in the 
MAL-ED cohort study by 
quantitative PCR
Error bars show 95% CI. 
ETEC=enterotoxigenic E coli. 
tEPEC=typical 
enteropathogenic E coli. 
EAEC=enteroaggregative 
E coli. aEPEC=atypical 
enteropathogenic E coli. 
STEC=Shiga toxin-producing 
E coli. 
Rotavirus
Adenovirus 40/41
Sapovirus
Norovirus
ETEC
Campylobacter jejuni or C coli
Astrovirus
Shigella
tEPEC
Cryptosporidium
EAEC
Giardia
aEPEC
Salmonella
Entamoeba histolytica
Plesiomonas
Vibrio cholerae
Cyclospora
Trichuris
Isospora
Helicobacter pylori
Enterocytozoon bieneusi
Aeromonas
Ancylostoma
Encephalitozoon intestinalis
Strongyloides
STEC
A
Shigella
Sapovirus
ETEC
Rotavirus
Adenovirus 40/41
Astrovirus
Norovirus
Campylobacter jejuni or C coli
Cryptosporidium
tEPEC
EAEC
Plesiomonas
Isospora
Giardia
aEPEC
Enterocytozoon bieneusi
Cyclospora
Vibrio cholerae
Strongyloides
Ancyclostoma
Entamoeba histolytica
Helicobacter pylori
Salmonella
Encephalitozoon intestinalis
STEC
Aeromonas
Trichuris
0 5 10 15 20 25 30
Attributable incidence per 100 child-years
35 40 45 50
B
0–11 months
12–24 months
Downloaded for Anonymous User (n/a) at Aga Khan University from ClinicalKey.com by Elsevier on October 30, 2018.
For personal use only. No other uses without permission. Copyright ©2018. Elsevier Inc. All rights reserved.
Articles
6 www.thelancet.com/lancetgh   Published online October 1, 2018   http://dx.doi.org/10.1016/S2214-109X(18)30349-8
Overall, 64·9% (95% CI 62·6–71·2) of diarrhoea 
episodes could be attributed to an infectious aetiology by 
quantitative PCR versus 32·8% (30·8–38·7) with the 
original microbiology (appendix). Among the top ten 
aetiologies, pathogen-attributable diarrhoeal burden was 
markedly increased for adenovirus 40/41 and Shigella, and 
to a lesser degree for astrovirus, enterotoxigenic E coli, 
and typical EPEC. Sapovirus was not tested for in the 
original MAL-ED study.13 The proportion of diarrhoea that 
was attributable to pathogens was higher in the second 
year of life than the first year of life (82·8% [95% CI 
78·7–91·1] vs 50·5%, [47·2–56·2]). Overall, viral diarrhoea 
(36·4%, 95% CI 33·6–39·5) was more common than 
bacterial (25·0%, 23·4–28·4) and parasitic diarrhoea 
(3·5%, 3·0–5·2). In the second year of life, the proportion 
of attribution to bacterial diarrhoea (43·3% in the second 
year vs 31·9% in the first year) and parasitic diarrhoea 
(6·8% vs 3·9%) increased, whereas the proportion of 
attribution to viral diarrhoea decreased (49·9% vs 64·2%).
Next, we assessed the association between pathogen 
attribution and distinguishing clinical characteristics 
(table 2). Shigella diarrhoea was associated with blood in 
Blood in stool 
(n=315)
Fever 
(n=2170)
Prolonged duration* 
(n=1381)
Dehydration 
(n=692)
Vomiting 
(n=1778)
High frequency† 
(n=1697)
Severe‡ § 
(n=1120)
Bacteria
Campylobacter jejuni 
or C coli
4·53 (2·71–7·57) 1·30 (0·98–1·72) 1·19 (0·82–1·73) 0·59 (0·33–1·09) 0·68 (0·48–0·97) 1·08 (0·76–1·54) 0·69 (0·42–1·11)
tEPEC 0·24 (0·07–0·87) 1·19 (0·84–1·70) 1·09 (0·69–1·70) 0·94 (0·48–1·84) 0·99 (0·64–1·52) 0·82 (0·53–1·27) 1·36 (0·84–2·19)
ETEC 0·54 (0·29–1·02) 0·98 (0·77–1·25) 0·96 (0·69–1·34) 1·23 (0·78–1·93) 1·11 (0·87–1·41) 1·21 (0·94–1·57) 1·37 (0·98–1·92)
Shigella 7·39 (5·20–10·49) 1·32 (1·10–1·58) 1·66 (1·31–2·10) 1·55 (1·11–2·16) 0·81 (0·65–1·02) 1·73 (1·40–2·14) 1·28 (0·96–1·70)
Viruses
Adenovirus 40/41 1·06 (0·55–2·06) 1·22 (0·92–1·62) 0·87 (0·58–1·29) 2·14 (1·24–3·69) 1·29 (0·99–1·68) 0·95 (0·70–1·29) 1·36 (0·91–2·01)
Astrovirus 0·24 (0·09–0·62) 0·92 (0·71–1·20) 0·78 (0·55–1·11) 1·38 (0·90–2·12) 1·10 (0·83–1·46) 1·23 (0·92–1·65) 1·09 (0·75–1·58)
Norovirus 0·45 (0·20–0·99) 0·79 (0·58–1·07) 0·66 (0·44–1·00) 1·59 (0·95–2·67) 1·81 (1·36–2·42) 0·86 (0·61–1·23) 1·38 (0·91–2·09)
Rotavirus 0·46 (0·24–0·89) 1·47 (1·24–1·74) 0·79 (0·60–1·04) 3·23 (2·44–4·28) 2·31 (1·97–2·72) 1·66 (1·38–1·99) 2·46 (1·99–3·06)
Sapovirus 0·39 (0·21–0·74) 0·84 (0·68–1·05) 0·83 (0·62–1·11) 1·21 (0·84–1·74) 1·51 (1·22–1·88) 1·01 (0·79–1·29) 1·12 (0·83–1·53)
Protozoa
Cryptosporidium 0·25 (0·06–1·00) 1·26 (0·87–1·84) 1·50 (0·93–2·43) 1·57 (0·83–2·95) 1·27 (0·82–1·96) 1·06 (0·64–1·75) 1·29 (0·71–2·33)
No aetiology identified 0·69 (0·50–0·96) 0·84 (0·75–0·96) 1·03 (0·88–1·21) 0·48 (0·38–0·60) 0·61 (0·53–0·70) 0·72 (0·62–0·83) 0·59 (0·49–0·70)
Data are prevalence ratio (95% CI). tEPEC=typical enteropathogenic E coli. ETEC=enterotoxigenic E coli. *Diarrhoea for 7 days or longer. †More than six loose stools in 24 h. ‡Severity score of 6 or higher. §Score derived 
from components of the Vesikari score.14 Analysis includes all episodes of diarrhoea with complete valid quantitative PCR results and clinical characteristics for the ten pathogens listed (n=6676).
Table 2: Clinical features associated with aetiology-specific diarrhoea
Figure 2: Attributable incidence of pathogen-specific diarrhoea by site in the MAL-ED cohort study by quantitative PCR
The ten pathogens with the highest overall attributable incidence are shown. Error bars show 95% CI. ETEC=enterotoxigenic E coli. tEPEC=typical enteropathogenic 
E coli. *Sites where rotavirus vaccine has been added to the national immunisation schedule.
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stool, fever, prolonged duration, dehydration, and high 
frequency, whereas rotavirus diarrhoea was associated 
with fever, vomiting, dehydration, high frequency, and 
high severity. All viral causes, with the exception of 
astrovirus, were associated with vomiting. Non-infectious 
diarrhoea was associated with the absence of each clinical 
characteristic with the exception of prolonged duration. 
Notably, 86·2% of the attributable incidence for Shigella 
was non-dysenteric (appendix).
Using detection at any quantity, diarrhoeal stools had 
a mean of 3·4 pathogens (SD 2·0) compared with 
2·5 pathogens (1·8) in non-diarrhoeal stools (p<0·001). 
Using a stringent quantitative cutoff to identify episode-
level aetiology (appendix), 2243 (33·9%) of 6625 episodes 
had one pathogen, and 644 (9·7%) of 6625 episodes 
had two or more pathogens (figure 3A). Frequently, no 
infectious aetiology was identified for diarrhoeal episodes 
that occurred in the first 6 months of life (appendix). 
Among episodes with multiple aetiologies, rotavirus 
and Shigella were usually the primary aetiologies, where-
as typical enteropathogenic E coli, adenovirus 40/41, 
and C jejuni or C coli were often secondary aetiologies 
(figure 3B). The clinical phenotype of diarrhoea was 
altered by co-pathogens. Among 1915 episodes with a 
viral aetiology, co-attribution to Shigella was associated 
with presence of blood (prevalence ratio 12·74, 95% CI 
5·94–27·31) and prolonged duration (2·33, 1·44–3·78). 
Among 1264 epi sodes with a bacterial aetiology, 
co-attribution to viral pathogens was associated with the 
absence of blood (prevalence ratio 0·57, 95% CI 
0·34–0·96) and vomiting (1·55, 1·11–2·16).
Because of the high Shigella burden, the suspected 
benefit of treating Shigella independent of the presence 
of blood, and because only a small minority of Shigella 
diarrhoea episodes were dysenteric, we evaluated 
whether other clinical characteristics could help inform 
treatment decisions (table 3). We found that a prediction 
score could identify most cases of Shigella diarrhoea 
(sensitivity 50·4% [95% CI 46·7–54·1], specificity 
84·0% [83·0–84·9], area under the curve [AUC] 0·783; 
table 3) and the prediction scores were consistent across 
sites with a high burden of disease (appendix). Age 
was an important determinant; diarrhoeal stools in 
children aged 6 months or younger were never positive, 
diarrhoeal stools in children aged between 7–12 months 
were positive only in the case of bloody diarrhoea, and 
in the second year of life a broader combination of 
clinical characteristics was sufficient. Complete score 
components are shown in the appendix. This Shigella 
score performed better than the presence of blood alone, 
which is used in current guidelines as an indication for 
treatment of shigellosis (sensitivity 14·5% [95% CI 
12·1–17·3], specificity 96·5% [96·0–97·0], AUC 0·555; 
table 3). Among Shigella diarrhoea episodes, longer 
duration was associated with maternal report of blood 
(odds ratio 1·10 per additional day of diarrhoea, 95% CI 
1·02–1·18), suggesting bloody diarrhoea was a late 
manifestation of disease. The performance of the Shigella 
score was slightly improved in the subset of moderate-to-
severe diarrhoea (AUC 0·824; appendix). Clinical 
prediction scores performed less well for other pathogens 
(table 3; appendix).
Overall, 3142 (47·1%) of 6676 diarrhoeal episodes in the 
MAL-ED observational cohort study were treated with 
an antibiotic. Defining appropriate antibiotic treatment 
Figure 3: Aetiologic detections and co-infections in diarrhoea episodes
(A) Number of pathogens detected in diarrhoea episodes. Aetiologic quantity was defined as an AFe of 0·5 or 
more. (B) Distribution of pathogen detections, stratified by aetiologic attribution. When more than one aetiologic 
detection was present, the primary aetiology was defined as the pathogen with the highest AFe. Pathogens are 
ordered according to the proportion of aetiologic detections for which they were the primary aetiology. 
Cq=quantification cycles. ETEC=enterotoxigenic E coli. tEPEC=typical enteropathogenic E coli. AFe=attributable 
fraction for that episode.
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Non-aetiologic detection
Secondary aetiology
Primary aetiology
Only aetiology
At aetiologic quantity
At any quantity (Cq <35)
Disease Positive episodes, 
% (SD)
Sensitivity, 
% (95% CI)
Specificity, 
% (95% CI)
AUC
Presence of blood 
(WHO guideline7)
Shigella diarrhoea 315 (4·7) 14·5 (12·1–17·3) 96·5 (96·0–97·0) 0·555
Shigella score Shigella diarrhoea 1322 (19·8) 50·4 (46·7–54·1) 84·0 (83·0–84·9) 0·783
Viral score Viral diarrhoea 1462 (21·9) 33·9 (31·8–36·1) 82·9 (81·8–84·0) 0·659
Cryptosporidium 
score
Cryptosporidium 
diarrhoea
957 (14·3) 36·1 (27·5–45·4) 86·1 (85·2–86·9) 0·701
Analysis included all episodes of diarrhoea with complete valid quantitative PCR results and clinical characteristics for 
the top ten pathogens (n=6676). AUC=area under the curve of the receiver operating characteristic curve.
Table 3: Model-based prediction of diarrhoea aetiology
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post hoc, as treatment of Shigella diarrhoea with either 
a macrolide or a fluoroquinolone, only 260 (8·3%) of 
all 3142 antibiotic courses for diarrhoea were appro-
priate (table 4). Of 736 Shigella diarrhoea episodes, 
260 (35·3%) were treated appropriately, 190 (25·8%) were 
treated inappropriately, and 286 (38·9%) were not 
treated. Taken together, this translates to one appro-
priately treated episode of Shigella diarrhoea for every 
12·2 diarrhoea episodes that were treated inappropriately. 
Adherence to existing WHO guidelines would greatly 
restrict antibiotic use, in that only 315 (4·7%) of 
6676 bloody diarrhoea episodes would be treated. How-
ever, only 107 (14·5%) of 736 Shigella episodes would be 
treated, with one appropriately treated episode for every 
7·8 episodes treated inappropriately. Application of the 
Shigella score would treat about half of all Shigella 
episodes, while improving the efficiency of antibiotic 
use, with one appropriate episode treated for every 
3·5 episodes treated inappropriately.
Discussion
In this study, the application of quantitative molecular 
diagnostics substantially altered previous estimates of 
diarrhoea aetiology obtained from the prospective, 
multisite MAL-ED cohort study. Of the five pathogens 
with highest overall attributable incidence of diarrhoea, 
only rotavirus and enterotoxigenic E coli, were in the 
top five using the original microbiological work-up.14 
Although underattribution to Shigella by traditional 
bacteriology has been previously documented,6 under-
attribution was substantially higher in this study: 
quantitative PCR showed that the Shigella burden was 
more than five times higher than the burden estimated by 
culture. In the second year of life, more than one of every 
five attributable episodes was Shigella diarrhoea. Although 
evidence6 also suggests that the burden of adenovirus 
40/41 has been substantially underestimated, sapovirus 
had the second highest overall attributable incidence of 
diarrhoea in these diverse community settings, which is 
notable. A high prevalence of sapovirus diarrhoea has 
been reported previously,25 but not across such diverse 
geographical locations. The burden of astrovirus 
diarrhoea was also higher than previously estimated. 
Among the ten pathogens that were responsible for the 
majority of cases of infectious diarrhoea, considerable 
heterogeneity was observed in the pathogen hierarchy by 
site. In comparison to the Global Enteric Multicenter 
Study,6 in which a similar quantitative PCR analysis was 
done, this cohort study captured the full denominator of 
diarrhoea severity in the community setting. However, 
four of the top five aetiologies (Shigella, rotavirus, 
adenovirus 40/41, and enterotoxigenic E coli) were shared. 
The modelled associations between pathogen quantity 
and diarrhoea were largely consistent between the two 
studies (appendix).
In this re-analysis of the MAL-ED community-based 
cohort study with active surveillance for diarrhoea, 
nearly two-thirds of diarrhoea could be attributed to a 
pathogen by quantitative PCR, with a large increase in 
attribution in the second year of life. We have previously 
shown that quantitative PCR further narrowed this 
aetiologic gap for severe diarrhoea,6 suggesting that a 
sizeable proportion of diarrhoea collected in this study 
in the first year of life might be non-infectious. Although 
we used a standardised diarrhoea definition of three or 
more loose stools in a 24 h period, this definition can 
lack specificity in young children and those who are 
exclusively breastfed.26
Diarrhoea is a syndrome with many causes, and the 
clinical determination of aetiology on the basis of the 
diarrhoea episode is difficult. We identified some 
phenotypes of aetiology-specific diarrhoea, with rotavirus 
and Shigella most strongly associated with specific 
characteristics. In comparison, enterotoxigenic E coli 
episodes were poorly differentiated, thus a tailored 
clinical case definition for interventional studies might be 
difficult.27 Despite using a stringent metric to identify 
aetiology for individual episodes, we found multiple 
aetiologies in one of every five episodes in which an 
infectious aetiology was found. The presence of 
copathogens predictably altered the clinical phenotype, 
suggesting that interventional studies that do not acc ount 
for co-pathogens in pathogen-specific case definitions 
might bias efficacy estimates towards the null.
Shigella diarrhoea (n=736) Non-Shigella diarrhoea (n=5940) Ratio of appropriate to either 
inappropriate treatment or 
non-treatment*
Appropriate 
antibiotics
Inappropriate 
antibiotics
Inappropriately 
not treated
Inappropriate 
antibiotics
Not treated
Observed in this study 260 (35·3%) 190 (25·8%) 286 (38·9%) 2692 (45·3%) 3248 (54·7%) 260:3168 (1:12·2)
Presence of blood 
(WHO guideline)
107 (14·5%) NA 629 (85·5%) 208 (3·5%) 5732 (96·5%) 107:837 (1:7·8)
Shigella clinical score 371 (50·4%) NA 365 (49·6%) 951 (16·0%) 4989 (84·0%) 371:1316 (1:3·5)
Data are n (%), unless otherwise specified. Analysis includes all episodes of diarrhoea with complete valid quantitative PCR results and clinical characteristics for the top 
ten pathogens (n=6676). NA=not applicable. *Numbers in parentheses represent the ratio of appropriate to either inappropriate treatment or non-treatment per 
appropriate treatment.
Table 4: Potential impact of adherence to current guidelines or the model-based prediction score on appropriate antibiotic use for diarrhoea
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In this study, we found that blood in stool is a poor 
marker for shigellosis, which is consistent with the 
conclusions of previous studies.6,9,10 Shigella has been 
associated with mortality in similar resource-limited 
settings, an association that extends beyond dysentery,10 
and in the companion Article by Rogawski and colleagues28 
Shigella infection was strongly associated with linear 
growth deficits. Thus, it is possible that current indications 
for antibiotic treatment of diarrhoea are too restrictive.7,10 A 
previous clinical trial29 found that watery Shigella responds 
to treatment, and a randomised controlled trial 
(NCT03130114) of antibiotic therapy for non-dysenteric 
diarrhoea in high-risk children is ongoing. If treatment of 
non-dysenteric Shigella is found to be beneficial, in the 
absence of point-of-care testing, an improved syndromic 
approach could be of benefit. In this study, in addition to 
blood in stool, incorporation of other clinical characteristics 
stratified by age improved identification of shigellosis.
We have previously reported antibiotic use at these 
eight sites (4·9 courses per child-year),8 but a substantial 
proportion of cases did not seem to be clinically 
indicated. Almost half of all diarrhoea episodes in this 
study were treated with antibiotics, and based on a 
quantitative PCR gold standard, 91·7% of these 
antibiotic courses were inappropriate. Since almost 
1 billion episodes of diarrhoea occur annually in 
children aged 5 years or younger,1 this translates to a 
substantial amount of inappropriate antibiotic exposure, 
which is high even in comparison to the amount 
of inappropriate antibiotic prescribed in developed 
countries for respiratory infections.30 Better adherence to 
guidelines is clearly needed,8 however the guidelines 
could also be revisited in view of improved data on 
diarrhoeal aetiology. We provide proof of concept that the 
use of readily-available criteria could reduce under-
treatment of shigellosis with a modest trade-off of 
increased inappropriate antibiotic treatment. However, 
an accurate point-of-care diagnostic could offer substantial 
additional benefit. Optimisation of antimicrobial use is a 
strategic objective of the WHO Global Action Plan on 
antimicrobial resistance, and we agree with calls31 that 
guidelines should consider inappropriate antibiotic use 
during their development process.
This study has several limitations. First, the MAL-ED 
cohort study was designed to investigate long-term 
sequelae of early enteric infections, and thus was not 
powered for diarrhoea aetiology at the level of the site, 
and diarrhoeal severity was lower than studies done in 
the health-care setting. Application of these diagnostics 
in broader surveillance networks can help extend these 
estimates.1,5 We identified a score for shigellosis to show 
that the syndromic treatment of diarrhoea could be 
improved, however any score for clinical use would need 
prospective derivation and validation, ideally in a study 
that can also assess the efficacy of such an approach. Our 
score is derived using the complete clinical phenotype of 
each diarrhoea episode, whereas less information will be 
available at the point of care, and early case detection and 
management in the setting of active surveillance might 
have changed the natural history of diarrhoea in patients 
that would otherwise have presented for care. Our 
definition of appropriate antibiotic use assumes a benefit 
for treatment of non-dysenteric Shigella and no benefit 
for treatment of other bacterial causes, and trials of 
expanded antibiotic treatment for diarrhoea are urgently 
needed to test this assumption. Without such data, 
modification of the current clinical algorithm is 
premature. Futhermore, our definition of appropriate 
antibiotic use takes into account local susceptibility 
information, but the evolution of antimicrobial resistance 
could alter this.
In summary, using quantitative molecular diagnostics 
we were able to identify ten pathogens responsible for 
the majority of community-based childhood infectious 
diarrhoea in diverse low-resource settings, including 
several pathogens for which burdens have been 
previously substantially underestimated. Although most 
cases of infectious diarrhoea were of viral aetiology, 
Shigella had the single highest attributable incidence. 
However, less than one in five episodes of shigellosis 
were accompanied by blood in stool. If non-dysenteric 
Shigella requires antibiotic therapy, it might be possible 
to leverage clinical characteristics to improve guidelines 
for the syndromic management of childhood diarrhoea 
in these settings.
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